LEVOPHED
These highlights do not include all the information needed to use LEVOPHED safely and effectively. See full prescribing information for LEVOPHED. LEVOPHED (norepinephrine bitartrate) injection, for intravenous use Initial U.S. Approval: 1950
Approved
Approval ID
c4de72a8-2a75-4984-ce90-e4870226dc12
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 2, 2020
Manufacturers
FDA
Hospira, Inc.
DUNS: 141588017
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
NOREPINEPHRINE BITARTRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0409-3375
Application NumberNDA007513
Product Classification
M
Marketing Category
C73594
G
Generic Name
NOREPINEPHRINE BITARTRATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 31, 2020
FDA Product Classification
INGREDIENTS (3)
NOREPINEPHRINE BITARTRATEActive
Quantity: 1 mg in 1 mL
Code: IFY5PE3ZRW
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM METABISULFITEInactive
Code: 4VON5FNS3C
Classification: IACT
NOREPINEPHRINE BITARTRATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0409-1443
Application NumberNDA007513
Product Classification
M
Marketing Category
C73594
G
Generic Name
NOREPINEPHRINE BITARTRATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 31, 2020
FDA Product Classification
INGREDIENTS (3)
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
NOREPINEPHRINE BITARTRATEActive
Quantity: 1 mg in 1 mL
Code: IFY5PE3ZRW
Classification: ACTIM
SODIUM METABISULFITEInactive
Code: 4VON5FNS3C
Classification: IACT